Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold
Authors:
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (3) , 747-757
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (8170130685)
- Jiangsu Natural Science Foundation of China (SBK2016043296)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (16KJB350003)
This publication has 29 references indexed in Scilit:
- Development of a histone deacetylase 6 inhibitor and its biological effectsProceedings of the National Academy of Sciences, 2013
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell GrowthJournal of Medicinal Chemistry, 2012
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase FamilyCancer Research, 2012
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in CancerClinical Cancer Research, 2012
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2011
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer ActivityCancer Research, 2010
- The roles of the FGF signal in zebrafish embryos analyzed using constitutive activation and dominant-negative suppression of different FGF receptorsMechanisms of Development, 2009
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor EfficacyCancer Research, 2008
- Multi-target therapeutics: when the whole is greater than the sum of the partsDrug Discovery Today, 2007
- Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancerCancer, 1975